From first to second wave: follow-up of the prospective COVID-19 cohort (KoCo19) in Munich (Germany).
Katja RadonAbhishek BakuliPeter PützRonan Le GleutJessica Michelle Guggenbuehl NollerLaura OlbrichElmar SaathoffMercè GaríYannik SchälteTurid FrahnowRoman WölfelMichael PritschCamilla RotheMichel PletschetteRaquel Rubio-AceroJessica BeyerlDafni MetaxaFelix ForsterVerena ThielNoemi CastellettiFriedrich RießMaximilian N DiefenbachGünter FröschlJan BrugerSimon WinterJonathan FreseKerstin PuchingerIsabel BrandInge KroidlAndreas WieserMichael HoelscherJan HasenauerChristiane Fuchsnull nullPublished in: BMC infectious diseases (2021)
The number of citizens in Munich with SARS-CoV-2 antibodies was still below 5% during the 2nd wave of the pandemic. Antibodies remained present in the majority of SARS-CoV-2 sero-positive baseline participants. Besides age and sex, potentially confounded by differences in behaviour, no major risk factors could be identified. Non-pharmaceutical public health measures are thus still important.